|
|
|
Bryan Byong Jin Kim, D.M.D., President and CEO Dr. Kim has had extensive experience in
building successful organizations throughout his career. During
his tenure as Director and Senior Director of Corporate Development
at VGX Pharmaceuticals, Dr. Kim has played an important role in
the acquisition of VGX International, Inc. in 2005 as well as the
day-to-day management of this publicly-traded bio-pharmaceutical
company in Korea. VGX International was added to a KOSPI 200 index
in 2007. He also successfully launched 3 business units: new drug
development, CMO and cGMP consulting at VGX International. Jay J. Surh, Chief Financial Officer, Vice President Mr. Surh has over 30 years
of experiences in various industries ranging from textile trading
to IT related ventures. He started his career, right after his MBA
studies, as an Executive Trainee of IBM Korea. Since then, he began
accumulating knowledge and experiences in various industries including
textile trading, IT, computers, engineering, finance/accounting,
and construction. His career in these industries not only presented
him with various experiences but also exposed him to valuable international
business scenes. Later he became an entrepreneur himself, leading
an internet related joint venture in San Diego, California. Recently
he worked, as a Senior Advisor, for a venture capital investment
company specialized in incubating young and small companies. In
October, 2005, he joined VGX International, Inc. that then was in
the process of acquiring a publicly held corporation in Korea, as
Executive Director in charge of Finance/Accounting. This new position
enables him to exercise and capitalize knowledge and experience
he has been accumulating through 30 years of his careers for the
company, which he is now determined to extend over to VGXI, Inc.,
a new subsidiary of VGX International, as CFO. Henry Hebel, Chief Operating Officer, Vice President Mr. Hebel joined VGX (Advisys) in 2001. He was previously employed by Qiagen Inc., where he served as Key Account Manager for a strategic joint venture known as the “pAlliance.” Mr. Hebel worked on the team that launched this venture and was responsible for sales, marketing, and project management activities. For six years prior to his work at Qiagen, Mr. Hebel worked for GeneMedicine Inc., which eventually merged to become Valentis, Inc. During this period, Mr. Hebel served as Senior Manager of Bioprocessing. The Bioprocessing team designed, built and operated a cGMP manufacturing facility that was responsible for human clinical batches through Phase II trials, as well as developed novel manufacturing techniques to allow for the scale up of plasmid processes. Mr. Hebel has additional development and manufacturing experience from Tanox Biosystems, Inc. In his position at Tanox, Mr. Hebel worked on antibody product development. Mr. Hebel holds a Bachelor of Science degree in zoology from Texas A&M University.
Robert J. Juba, Sr. Director, Manufacturing & Technical Services Mr. Juba has been with VGX since September 2005, after 11 years of experience in the pharmaceutical industry at Merck & Co. He has managed several contract manufacturing and filling projects for developmental products (Vaccines for Rotavirus and HIV-1), led pilot plant operations for research and clinical supply manufacturing, and provided technical expertise for bacterial vaccine manufacturing. He has extensive experience in managing cGMP processes and operations. Mr. Juba holds both Bachelor's and Master's Degrees in Chemical Engineering from the Massachusetts Institute of Technology. Dorothy Peterson, Sr. Director of Quality Ms. Peterson comes to VGX with over 20 years experience in the medical device industry, complying with FDA regulations in both start up and established organizations. Ms. Peterson recently relocated to Houston, TX from San Diego, CA where she was VP of Operations at Qualigen, Inc. which included the responsibility for quality and regulatory. While at Qualigen, she successfully submitted several 510(k) applications and led the company through multiple regulatory agency audits including ISO 13485 to gain the CE mark. Prior to Qualigen, Ms. Peterson was at Hybritech, Inc. (a subsidiary of Beckman-Coulter) for 14 years where she held multiple positions in both the quality and manufacturing organizations. Ms. Peterson received her Bachelor of Science in Biology from Sam Houston State University in Huntsville, Texas. She is also a member of the Regulatory Affairs Professional Society.
|
|||
 |
